Carcinoembryonic antigen (CEA) is a glycoprotein belonging to the immunoglobulin superfamily, normally expressed at very low levels in healthy adult tissues but significantly elevated in certain malignancies. It serves as a widely used tumor marker for monitoring disease progression, recurrence, and treatment response, primarily in colorectal cancer, but also in breast, lung, pancreatic,...

"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021. By considering a definite base year and historic year, calculations in the...

"Executive Summary Europe Circulating Tumor Cells (CTC) Liquid Biopsy Market Size and Share Forecast Data Bridge Market Research analyses that the market is growing with a CAGR of 24.3% in the forecast period of 2022 to 2029 and is expected to reach USD 1,891.60 million by 2029 from USD 351.05 million in 2021.  By considering a definite base year and historic year, calculations...

"Executive Summary North America Circulating Tumor Cells (CTC) Liquid Biopsy Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the market is growing with a CAGR of 25.9% in the forecast period of 2022 to 2029 and is expected to reach USD 2,650.96 million by 2029 from USD 442.64 million in 2021.  The key topics that have been described in this...